GPT Healthcare Ltd Stock Price Today (NSE: GPTHEALTH)

GPT Healthcare Ltd

GPTHEALTHHospital
151.41+8.28 (+5.79%)
Market Closed

Fundamental Score

...

GPT Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

GPT Healthcare Ltd share price today is 151.41, up +5.79% on NSE/BSE as of 2 June 2026. GPT Healthcare Ltd (GPTHEALTH) is a Small-cap company in the Hospital sector with a market capitalisation of 1.15K (Cr). The 52-week high for GPTHEALTH share price is 185.00 and the 52-week low is 115.00. At a P/E ratio of 26.40x, GPTHEALTH is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 21.30% and a debt-to-equity ratio of 0.38.

GPT Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
152.85
Low
135.55
Volume
1.3L
Change
+7.04%

GPT Healthcare Ltd share price chart: 7.04% return over the past month. 52-week high ₹185.00, 52-week low ₹115.00.

GPT Healthcare Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
143.00152.85141.02151.414.18L (Cr)
141.20144.55141.20143.1351.90K (Cr)
141.00147.00140.77142.402.19L (Cr)
139.92139.92139.92139.920.00 (Cr)
140.58142.95139.02139.9291.79K (Cr)
140.29142.00138.78139.1235.52K (Cr)
142.50142.80138.50139.2661.10K (Cr)
140.10141.54138.52139.9966.11K (Cr)
142.88143.35140.00140.6575.22K (Cr)
140.70144.99140.04141.9181.27K (Cr)

GPT Healthcare Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
141.20152.85141.02151.41+7.23%
135.55147.28135.55142.40+5.05%
119.70141.50115.00138.43+15.65%
121.11127.49115.00115.31-4.79%
128.00135.89121.40126.26-1.36%
140.00144.49124.90130.19-7.01%
143.10144.80132.30140.35-1.92%
148.95151.00140.05141.68-4.88%
147.86153.90145.29148.64+0.53%
148.98160.30145.45147.13-1.24%
172.00185.00147.16148.13-13.88%
144.20179.80139.99176.54+22.43%

AI Research Briefing

Powered by Gemini · 2026-04-15

Eastern India healthcare play faces execution headwinds and management transition.

Research Confidence
6.0/10Moderate
COMPOUNDER1M: -5.9%, 3M: -5.9%, 6M: -6.49% indicates consolidation [cite: brief].P/E of 26.4x vs Industry P/E of 52.84x [cite: brief] suggests fair valuation.

WHAT'S HAPPENING NOW (last 2-4 weeks)

GPT Healthcare announced the resignation of Mr. Debashis Dhar, Senior Vice President and Chief Business Development Officer, effective April 2, 2026, due to personal reasons. The company also submitted its Q4FY26 compliance certificate under SEBI regulations, reporting no dematerialization or rematerialization requests during the quarter.

CORE STORY (THE REAL GAME)

GPT Healthcare is a play on the rising demand for healthcare services in Eastern India, particularly leveraging its ILS Hospitals brand in a region with a growing need for quality healthcare and a rising influx of international patients. The focus is on expanding within Eastern India and capitalizing on strategic locations near transport hubs.

Why Now
  • Rising healthcare demand in Eastern India
  • Strategic locations in dense residential areas
  • Focus on operational efficiency
Potential Catalysts
  • Successful expansion in Eastern India
  • Improvement in occupancy rates
  • Effective cost management in newer facilities
Key Risks
  • Small-cap liquidity risk
  • Q3FY26 PAT declined 22% YoY
  • Senior management exit
Institutional Activity

FII decreased holdings by 1.76%, DII decreased holdings by 2.88% [cite: brief].

Macro Context

Eastern India emerging as a hub for international patients.

Cash Flow Quality

Free Cash Flow 5Y: ₹222.08 Cr [cite: brief] suggests profit converting to cash.

3–6 Month Outlook

Focus on improving occupancy and managing costs in newer facilities. Expansion in Eastern India remains key.

Primary Thesis Risk

Failure to improve occupancy and manage costs in newer facilities.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

21.30%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

27.23%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

21.09%

Average operating profit margin over 5 years

Good

Dividend Yield

1.79%

Annual dividend as % of current share price

GPT Healthcare Ltd Valuation Check

Excellent

Price to Earnings (P/E)

26.40x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

65.57%

% shares held by company founders/management

Poor

FII Holding

3.20%

% shares held by foreign institutional investors

Average

DII Holding

6.45%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-28.48%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

12.54%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

13.96%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-0.44%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

34.94%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.38x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

11.63x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

222.08 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

GPT Healthcare Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of GPTHEALTH across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (21.30%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (27.23%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (21.09%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 26.40 vs Industry: 52.84)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (13.96% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (34.94% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (11.63x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹222.08 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (65.57%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Profit Decline Concern (-28.48%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-0.44% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Limited Institutional Interest (FII+DII: 9.65%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

GPT Healthcare Ltd vs Hospital Peers

Peer Comparison - Hospital

Compare GPT Healthcare Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
61/100
151
₹1146.32
26.4
Average
21.30%
Excellent
27.23%
Excellent
0.4
Excellent
34.94%
Excellent
13.96%
Good
1.79%
69.1/100
949
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8090
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
929
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1934
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
727
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1199
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
45.1/100
746
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
51.2/100
477
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1341
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
632
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%

GPT Healthcare Ltd PE Ratio History

Historical price-to-earnings ratio for GPTHEALTH — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20256.08₹140.3523.1x
FY 20245.96₹183.9030.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

GPT Healthcare Ltd Dividend History

Annual cash dividends paid by GPTHEALTH — dividend yield 1.79%

Financial YearDividends Paid (₹ Cr)
FY 202528.72 Cr
FY 202423.97 Cr
FY 202331.96 Cr
FY 202217.26 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

GPT Healthcare Ltd Quarterly Performance

Latest quarterly metrics for GPTHEALTH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

12.54%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-28.48%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

13.96%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

34.94%

Compounded annual net profit growth over 5 years

GPT Healthcare Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for GPTHEALTH — calculated from daily price history

69RSI 14
Neutral — RSI 69

Momentum is balanced — neither overbought nor oversold.

SMA 50
135
▲ Price above SMA 50 — Short-term bullish
SMA 200
140
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
113K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

GPT Healthcare Ltd Financial Statements

Annual income statement, balance sheet and cash flow for GPT Healthcare Ltd (GPTHEALTH) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for GPT Healthcare Ltd

About GPTHEALTH (GPT Healthcare Ltd)

GPT Healthcare Ltd is a beacon of comprehensive care within the medical landscape, distinguished by its network of ILS Hospitals. These facilities are designed to provide a broad s...pectrum of medical services, attending to patients' diverse healthcare needs with a commitment to quality and patient-centricity. GPT Healthcare focuses on offering advanced diagnostic and therapeutic interventions, establishing itself as a trusted healthcare provider in its operational regions. The hospitals are staffed with skilled medical professionals, equipped with modern technology, and designed to create a healing environment, ensuring optimal patient outcomes. Within the walls of GPT Healthcare's ILS Hospitals, patients gain access to a coordinated array of specialized departments, each dedicated to specific areas of medicine. From the management of chronic conditions like diabetes by seasoned internists and diabetologists, to the intricate procedures performed by nephrologists, including life-saving renal transplants, GPT Healthcare displays a comprehensive approach to patient well-being. Complex laparoscopic and general surgeries are performed with precision, while the obstetrics and gynecology department provides complete care for women's health. The inclusion of critical care units emphasizes the organization's commitment to managing acute and severe illnesses with round-the-clock monitoring and immediate intervention. The range of services available at ILS Hospitals showcases GPT Healthcare's dedication to providing holistic healthcare solutions. Advanced procedures like robotic-assisted and bariatric surgery demonstrate a commitment to innovation and minimally invasive techniques. The cardiology department offers interventional procedures, while neurology and neurosurgery teams treat disorders of the nervous system. Pediatrics and neonatology departments are focused on the unique healthcare requirements of children and newborns. This comprehensive suite of services, combined with a focus on patient comfort and recovery, demonstrates GPT Healthcare's mission to improve lives through accessible and advanced medical care.

Company Details

Symbol:GPTHEALTH
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Om Prakash Tantia
Chairman & MD
Mr. Ankur Sharma
Company Secretary & Compliance Officer
Mr. Anurag Tantia
Executive Director

Corporate Events

Recent
Ex-Dividend Date

GPTHEALTH Share Price: Frequently Asked Questions

What is the current share price of GPT Healthcare Ltd?

GPT Healthcare Ltd (GPTHEALTH) trades at ₹151.41 on NSE and BSE. Market cap ₹1.15K (Cr). Educational data only.

What is the P/E ratio of GPT Healthcare Ltd?

GPT Healthcare Ltd has a P/E of 26.40x vs industry average 52.84x.

What is the Bull Run score for GPT Healthcare Ltd?

GPT Healthcare Ltd has a Bull Run score of 61/100 based on 25+ financial parameters.

Does GPT Healthcare Ltd pay dividends?

GPT Healthcare Ltd has a dividend yield of 1.79%. Past dividends don't guarantee future payments.

What is the ROE of GPT Healthcare Ltd?

GPT Healthcare Ltd has ROE of 21.30%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of GPT Healthcare Ltd?

GPT Healthcare Ltd has debt-to-equity of 0.38.

Is GPT Healthcare Ltd a good investment?

Bull Run gives GPT Healthcare Ltd a score of 61/100. This is not investment advice — consult a SEBI-registered advisor.